ReportsnReports - Kidney and Renal Diseases Therapeutics Market to 2017 – Strong Pipeline and Unmet Need Due to Poor Safety Profiles to Create Opportunities for Growth

  • 511 views
Uploaded on

GBI Research’s report, “Kidney and Renal Diseases Therapeutics Market to 2017 – Strong Pipeline and Unmet Need Due to Poor Safety Profiles and to Create Opportunities for Growth”, provides in-depth …

GBI Research’s report, “Kidney and Renal Diseases Therapeutics Market to 2017 – Strong Pipeline and Unmet Need Due to Poor Safety Profiles and to Create Opportunities for Growth”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global kidney and renal diseases therapeutics market.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
511
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Kidney and Renal Diseases Therapeutics Market to 2017 – Strong Pipeline andUnmet Need Due to Poor Safety Profiles to Create Opportunities for GrowthGBI Research’s report, “Kidney and Renal Diseases Therapeutics Market to 2017 – StrongPipeline and Unmet Need Due to Poor Safety Profiles and to Create Opportunities forGrowth”, provides in-depth analysis of unmet needs, drivers and barriers that impact theglobal kidney and renal diseases therapeutics market. Buy Now: Kidney and Renal Diseases Therapeutics MarketBrowse All: Latest Market Research ReportsThe report analyzes the markets for kidney and renal diseases therapeutics in the US, thetop five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan.Treatment usage patterns, sales, prices and volumes are forecast until 2017 for the keygeographies as well as the leading therapeutic segments. Further, the report providescompetitive benchmarking for the leading companies and analyzes the mergers, acquisitionsand licensing agreements that shape the global markets.ScopeThe scope of this report includes - Annualized market data for the kidney and renal diseases therapeutics market from 2001 to 2010, forecast forward to 2017 Analysis of the leading therapeutic segments. Analysis of the kidney and renal diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan Market characterization of the kidney and renal diseases therapeutics market including market size, annual cost of therapy, and treatment usage patterns Key drivers and barriers that have a significant impact on the market Coverage of pipeline molecules in various phases of drug development Competitive benchmarking of leading companies. Key M&A activities, licensing agreements, that have taken place between 2008 and 2010 in the global kidney and renal diseases therapeutics marketReasons to buyThe report will enhance your decision making capability. It will allow you to - Align your product portfolio to the markets with high growth potential. Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth. Reinforce R&D pipelines by identifying new target mechanisms which can produce first- in-class molecules with more efficiency and better safety.
  • 2.  Develop key strategic initiatives by understanding the key focus areas of leading companies. Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.Table of Contents1 Table of Contents 31.1 List of Tables 61.2 List of Figures 82 Introduction 102.1 GBI Research Report Guidance 113 Kidney and Renal Diseases Therapeutics Market to 2017: Market Overview 123.1 Introduction 123.2 Revenue Forecasts for the Global Kidney and Renal Disease Market 133.2.1 Revenue 133.2.2 Annual Cost of Treatment (ACT) 143.3 Treatment Usage Patterns 153.3.1 Diseased Population 173.3.2 Treatment Seeking Population 183.3.3 Diagnosis Population 193.3.4 Prescription Population 204 Kidney and Renal Diseases Therapeutics Market to 2017: GeographicalLandscape 214.1 Revenue Analysis by Geography 214.2 The US 234.2.1 Revenue 234.2.2 Annual Cost of Treatment 244.3 Top Five Countries of Europe 254.3.1 Revenue 254.3.2 Annual Cost of Treatment 264.4 Japan 274.4.1 Revenue 274.4.2 Annual Cost of Treatment 285 Kidney and Renal Diseases Therapeutics Market to 2017: Therapeutic Landscape295.1 Chronic Kidney Diseases Market 295.1.1 Introduction 295.1.2 Revenue 30
  • 3. 5.1.3 Annual Cost of Treatment 325.1.4 Treatment Usage Patterns 335.1.5 Drivers and Barriers for the Chronic Kidney Diseases Market 395.1.6 Drivers for the Chronic Kidney Disease Market 395.1.7 Barriers for the Chronic Kidney Disease Market 395.2 Renal Anemia Market 405.2.1 Introduction 405.2.2 Revenue 405.2.3 Annual Cost of Treatment 435.2.4 Treatment Usage Patterns 445.2.5 Drivers and Barriers for the Renal Anemia Market 505.2.6 Drivers for the Renal Anemia Market 515.2.7 Barriers for the Renal Anemia Market 515.3 Diabetic Nephropathy Market 525.3.1 Introduction 525.3.2 Revenue 525.3.3 Annual Cost of Treatment 555.3.4 Treatment Usage Patterns 565.3.5 Drivers and Barriers for the Diabetic Nephropathy Market 615.3.6 Drivers for the Diabetic Nephropathy Market 615.3.7 Barriers for the Diabetic Nephropathy Market 615.4 Acute Kidney Injury Market 625.4.1 Introduction 625.4.2 Revenue 635.4.3 Annual Cost of Treatment 655.4.4 Treatment Usage Patterns 675.4.5 Drivers and Barriers for the Acute Kidney Injury Market 735.4.6 Drivers for the Acute Kidney Injury Market 735.4.7 Barriers for the Acute Kidney Injury Nephropathy Market 736 Kidney and Renal Diseases Therapeutics Market to 2017 – Product PipelineAnalysis 746.1 Introduction 746.1.1 Research and Development Pipeline – Chronic Kidney Disease (CKD) 756.1.2 Research and Development Pipeline – Renal Anemia (RA) 816.1.3 Research and Development Pipeline – Diabetic Nephropathy (DN) 836.1.4 Research and Development Pipeline – Acute Kidney Injury (AKI) 866.2 Profiles of Promising Drugs in the Kidney and Renal Disease Market 896.2.1 AMG 223 896.2.2 AST-120 906.2.3 CellCept 906.2.4 Ferinject 91
  • 4. 6.2.5 Genz-644470 926.2.6 Hematide 936.2.7 HEPLISAV 936.2.8 Heptar 946.2.9 SBR759 956.2.10 Sulodexide 966.2.11 YM533 966.2.12 Zuragen 976.2.13 Olmetec 977 Kidney and Renal Diseases Therapeutics Market to 2017 – CompetitiveLandscape 997.1 Market Share Analysis 997.2 Amgen Inc. 1007.2.1 Company Overview 1007.2.2 Business Overview 1007.2.3 SWOT Analysis 1017.3 Merck & Co., Inc. 1027.3.1 Company Overview 1027.3.2 Business Overview 1027.3.3 SWOT Analysis 1037.4 Bristol-Myers Squibb Company 1047.4.1 Company Overview 1047.4.2 Business Overview 1047.4.3 SWOT Analysis 1057.5 Hoffmann-La Roche Inc. 1067.5.1 Company Overview 1067.5.2 Business Overview 1067.5.3 SWOT Analysis 1077.6 Shire Inc. 1087.6.1 Company Overview 1087.6.2 Business Overview 1087.6.3 SWOT Analysis 1098 Kidney and Renal Diseases Therapeutics Market to 2017 – M&A Landscape 1108.1 M&A Deals 1108.1.1 Deal Summary 1118.1.2 Deals by Geography 1138.2 Licensing Deals 1148.2.1 Summary of Licensing Deals (2009-2010) 1158.3 Co-development Deals 1178.3.1 Summary of Co-development Deals (2009-2010) 118
  • 5. 9 Kidney and Renal Diseases Therapeutics Market to 2017 – Appendix 1209.1 Market Definitions 1209.2 Abbreviations 1209.3 Research Methodology 1219.3.1 Coverage 1219.3.2 Secondary Research 1229.3.3 Primary Research 1229.3.4 Expert Panel Validation 1249.4 Contact Us 1249.5 Disclaimer 1249.6 Sources 1241.1 List of TablesTable 1: Kidney and Renal Diseases Therapeutics Market, Global, Revenue Forecasts ($bn),2002-2010Table 2: Kidney and Renal Diseases Therapeutics Market, Global, Revenue Forecasts ($bn),2010-2017Table 3: Kidney and Renal Diseases Therapeutics Market, Global, Annual Cost of Treatment($), 2002-2010Table 4: Kidney and Renal Diseases Therapeutics Market, Global, Annual Cost of Treatment($), 2010-2017Table 5: Kidney and Renal Diseases Therapeutics Market, Global, Treatment Usage Pattern(millions), 2002-2010Table 6: Kidney and Renal Diseases Therapeutics Market, Global, Treatment Usage Pattern(millions), 2010-2017Table 7: Kidney and Renal Diseases Therapeutics Market, Global, Revenue Analysis byGeography ($bn), 2002-2010Table 8: Kidney and Renal Diseases Therapeutics Market, Global, Revenue Analysis byGeography ($bn), 2010-2017Table 9: Kidney and Renal Diseases Therapeutics Market, The US, Revenue Forecasts ($bn),2002-2010Table 10: Kidney and Renal Diseases Therapeutics Market, The US, Revenue Forecasts($bn), 2010-2017Table 11: Kidney and Renal Diseases Therapeutics Market, The US, Annual Cost ofTreatment ($), 2002-2010Table 12: Kidney and Renal Diseases Therapeutics Market, The US, Annual Cost ofTreatment ($), 2010-2017Table 13: Kidney and Renal Diseases Therapeutics Market, Top Five Countries of Europe,Revenue Forecasts ($bn), 2002-2010Table 14: Kidney and Renal Diseases Therapeutics Market, Top Five Countries of Europe,Revenue Forecasts ($bn), 2010-2017
  • 6. Table 15: Kidney and Renal Diseases Therapeutics Market, Top Five Countries of Europe,Annual Cost of Treatment ($), 2002-2010Table 16: Kidney and Renal Diseases Therapeutics Market, Top Five Countries of Europe,Annual Cost of Treatment ($), 2010-2017Table 17: Kidney and Renal Diseases Therapeutics Market, Japan, Revenue Forecasts ($bn),2002-2010Table 18: Kidney and Renal Diseases Therapeutics Market, Japan, Revenue Forecasts ($bn),2010-2017Table 19: Kidney and Renal Diseases Therapeutics Market, Japan, Annual Cost of Treatment($), 2002-2010Table 20: Kidney and Renal Diseases Therapeutics Market, Japan, Annual Cost of Treatment($), 2010-2017Table 21: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease, GlobalRevenue Forecasts ($bn), 2002-2010Table 22: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease, GlobalRevenue Forecasts ($bn), 2010-2017Table 23: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease,Revenue by Geography ($bn), 2002-2010Table 24: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease,Revenue by Geography ($bn), 2010-2017Table 25: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease, AnnualCost of Treatment by Geography ($), 2002-2010Table 26: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease, AnnualCost of Treatment by Geography ($), 2010-2017Table 27: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease, GlobalTreatment Usage Pattern (millions), 2002-2010Table 28: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease, GlobalTreatment Usage Pattern (millions), 2010-2017Table 29: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Global RevenueForecasts ($bn), 2002-2010Table 30: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Global RevenueForecasts ($bn), 2010-2017Table 31: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Revenue byGeography ($bn), 2002-2010Table 32: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Revenue byGeography ($bn), 2010-2017Table 33: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Annual Cost ofTreatment by Geography ($), 2002-2010Table 34: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Annual Cost ofTreatment by Geography ($), 2010-2017Table 35: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Global TreatmentUsage Pattern (millions), 2002-2010
  • 7. Table 36: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Global TreatmentUsage Pattern (millions), 2010-2017Table 37: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, GlobalRevenue Forecasts ($bn), 2002-2010Table 38: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, GlobalRevenue Forecasts ($bn), 2010-2017Table 39: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, Revenueby Geography ($bn), 2002-2010Table 40: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, Revenueby Geography ($bn), 2010-2017Table 41: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, AnnualCost of Treatment by Geography ($), 2002-2010Table 42: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, AnnualCost of Treatment by Geography ($), 2010-2017Table 43: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, GlobalTreatment Usage Pattern (millions), 2002-2010Table 44: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, GlobalTreatment Usage Pattern (millions), 2010-2017Table 45: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, GlobalRevenue Forecasts ($bn), 2002-2010Table 46: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, GlobalRevenue Forecasts ($bn), 2010-2017Table 47: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, Revenue byGeography ($bn), 2002-2010Table 48: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, Revenue byGeography ($bn), 2010-2017Table 49: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, Annual Costof Treatment by Geography ($), 2002-2010Table 50: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, Annual Costof Treatment by Geography ($), 2010-2017Table 51: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, GlobalTreatment Usage Pattern (millions), 2002-2010Table 52: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, GlobalTreatment Usage Pattern (millions), 2010-2017Table 53: Research and Development Pipeline – Chronic Kidney Disease (CKD) – 2011Table 54: Research and Development Pipeline – Renal Anemia (RA) – 2011Table 55: Research and Development Pipeline – Diabetic Nephropathy (DN) – 2011Table 56: Research and Development Pipeline – Acute Kidney Injury (AKI) – 2011Table 57: Kidney and Renal Diseases Therapeutics Market, Global Major M&A Deals, 2004-2010Table 58: Kidney and Renal Diseases Therapeutics Market, Global Licensing Deals, 2004-2010
  • 8. Table 59: Kidney and Renal Diseases Therapeutics Market, Global Major Co-developmentDeals, 2004-20101.2 List of FiguresFigure 1: Kidney and Renal Diseases Therapeutics Market, Global, Revenue Forecasts ($bn),2002-2017Figure 2: Kidney and Renal Diseases Therapeutics Market, Global, Annual Cost of Treatment($), 2002-2017Figure 3: Kidney and Renal Diseases Therapeutics Market, Global, Treatment Usage Pattern(millions), 2002-2017Figure 4: Kidney and Renal Diseases Therapeutics Market, Global, Diseased Population(millions), 2002-2017Figure 5: Kidney and Renal Diseases Therapeutics Market, Global, Treatment SeekingPopulation (millions), 2002-2017Figure 6: Kidney and Renal Diseases Therapeutics Market, Global, Diagnosed Population(millions), 2002-2017Figure 7: Kidney and Renal Diseases Therapeutics Market, Global, Prescription Population(millions), 2002-2017Figure 8: Kidney and Renal Diseases Therapeutics Market, Global, Revenue Analysis byGeography ($bn), 2002-2017Figure 9: Kidney and Renal Diseases Therapeutics Market, The US, Revenue Forecasts($bn), 2002-2017Figure 10: Kidney and Renal Diseases Therapeutics Market, The US, Annual Cost ofTreatment ($), 2002-2017Figure 11: Kidney and Renal Diseases Therapeutics Market, Top Five Countries of Europe,Revenue Forecasts ($bn), 2002-2017Figure 12: Kidney and Renal Diseases Therapeutics Market, Top Five Countries of Europe,Annual Cost of Treatment ($), 2002-2017Figure 13: Kidney and Renal Diseases Therapeutics Market, Japan, Revenue Forecasts($bn), 2002-2017Figure 14: Kidney and Renal Diseases Therapeutics Market, Japan, Annual Cost ofTreatment ($), 2002-2017Figure 15: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease, GlobalRevenue Forecasts ($bn), 2002-2017Figure 16: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease,Revenue by Geography ($bn), 2002-2017Figure 17: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease, AnnualCost of Treatment by Geography ($), 2002-2017Figure 18: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease, GlobalTreatment Usage Pattern (millions), 2002-2017Figure 19: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease, GlobalDiseased Population (millions), 2002-2017
  • 9. Figure 20: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease, GlobalTreatment Seeking Population (millions), 2002-2017Figure 21: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease, GlobalDiagnosed Population (millions), 2002-2017Figure 22: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Disease, GlobalPrescription Population (millions), 2002-2017Figure 23: Kidney and Renal Diseases Therapeutics Market, Chronic Kidney Diseases, GlobalMarket Drivers and Barriers, 2010-2017Figure 24: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Global RevenueForecasts ($bn), 2002-2017Figure 25: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Revenue byGeography ($bn), 2002-2017Figure 26: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Annual Cost ofTreatment by Geography ($), 2002-2017Figure 27: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Global TreatmentUsage Pattern (millions), 2002-2017Figure 28: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Global DiseasedPopulation (millions), 2002-2017Figure 29: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Global TreatmentSeeking Population (millions), 2002-2017Figure 30: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Global DiagnosedPopulation (millions), 2002-2017Figure 31: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, GlobalPrescription Population (millions), 2002-2017Figure 32: Kidney and Renal Diseases Therapeutics Market, Renal Anemia, Global MarketDrivers and Barriers, 2010-2017Figure 33: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, GlobalRevenue Forecasts ($bn), 2002-2017Figure 34: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, Revenueby Geography ($bn), 2002-2017Figure 35: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, AnnualCost of Treatment by Geography ($), 2002-2017Figure 36: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, GlobalTreatment Usage Pattern (millions), 2002-2017Figure 37: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, GlobalDiseased Population (millions), 2002-2017Figure 38: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, GlobalTreatment Seeking Population (millions), 2002-2017Figure 39: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, GlobalDiagnosed Population (millions), 2002-2017Figure 40: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, GlobalPrescription Population (millions), 2002-2017
  • 10. Figure 41: Kidney and Renal Diseases Therapeutics Market, Diabetic Nephropathy, GlobalMarket Drivers and Barriers, 2010-2017Figure 42: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, GlobalRevenue Forecasts ($bn), 2002-2017Figure 43: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, Revenueby Geography ($bn), 2002-2017Figure 44: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, AnnualCost of Treatment by Geography ($), 2002-2017Figure 45: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, GlobalTreatment Usage Pattern (millions), 2002-2017Figure 46: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, GlobalDiseased Population (millions), 2002-2017Figure 47: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, GlobalTreatment Seeking Population (millions), 2002-2017Figure 48: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, GlobalDiagnosed Population (millions), 2002-2017Figure 49: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, GlobalPrescription Population (millions), 2002-2017Figure 50: Kidney and Renal Diseases Therapeutics Market, Acute Kidney Injury, GlobalMarket Drivers and Barriers, 2010-2017Figure 51: Kidney and Renal Diseases Therapeutics Market, Global Product Pipeline by Phase(%), 2011Figure 52: Research and Development Pipeline – Chronic Kidney Disease (CKD) – 2011Figure 53: Research and Development Pipeline – Renal Anemia (RA) – 2011Figure 54: Research and Development Pipeline – Diabetic Nephropathy (DN) – 2011Figure 55: Research and Development Pipeline – Acute Kidney Injury (AKI) – 2011Figure 56: Kidney and Renal Diseases Therapeutics Market, Global, Top Companies Share(%), 2009Figure 57: SWOT Analysis of Amgen Inc.Figure 58: SWOT Analysis of Merck & Co., Inc.Figure 59: SWOT Analysis of Bristol-Myers Squibb CompanyFigure 60: SWOT Analysis of RocheFigure 61: SWOT Analysis of ShireFigure 62: Kidney and Renal Diseases Therapeutics Market, Global, Major M&A Deals byGeography, 2005-2010Figure 63: Kidney and Renal Diseases Therapeutics Market, Global, Major Licensing Deals byGeography, 2005-2010Figure 64: GBI Research Market Forecasting Model
  • 11. Related Reports: Brazilian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems, Extraoral X-Ray Systems and CBCT Scanners) Russian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems, Extraoral X-Ray Systems and CBCT Scanners) Indian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems, Extraoral X-Ray Systems and CBCT Scanners) Chinese Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems, Extraoral X-Ray Systems and CBCT Scanners) U.S. Hyaluronic Acid Viscosupplementation Physician Survey 2011About UsReportsnReports is an online library of over 75,000 market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on: Twitter: http://twitter.com/marketsreports Facebook:http://www.facebook.com/pages/ReportsnReports/191441427571689 Blog : http://www.reportsnreportsblog.com/Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: +1-888-989-8004E-mail: sales@reportsnreports.comWebsite: http://www.reportsnreports.com